Science born out of Genzyme underpins new cystic-fibrosis startup

Sionna Therapeutics, a cystic fibrosis –focused company advancing science that dates back to storied biotech Genzyme, has launched and revealed $150 million in funding.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news